1. Home
  2. NFE vs AVDL Comparison

NFE vs AVDL Comparison

Compare NFE & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFE
  • AVDL
  • Stock Information
  • Founded
  • NFE 2014
  • AVDL 2015
  • Country
  • NFE United States
  • AVDL Ireland
  • Employees
  • NFE N/A
  • AVDL N/A
  • Industry
  • NFE Oil/Gas Transmission
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NFE Utilities
  • AVDL Health Care
  • Exchange
  • NFE Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • NFE 981.6M
  • AVDL 861.4M
  • IPO Year
  • NFE 2019
  • AVDL 1996
  • Fundamental
  • Price
  • NFE $3.78
  • AVDL $11.03
  • Analyst Decision
  • NFE Buy
  • AVDL Strong Buy
  • Analyst Count
  • NFE 7
  • AVDL 7
  • Target Price
  • NFE $12.79
  • AVDL $18.71
  • AVG Volume (30 Days)
  • NFE 13.3M
  • AVDL 1.2M
  • Earning Date
  • NFE 08-08-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • NFE N/A
  • AVDL N/A
  • EPS Growth
  • NFE N/A
  • AVDL N/A
  • EPS
  • NFE N/A
  • AVDL N/A
  • Revenue
  • NFE $2,127,808,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • NFE $9.21
  • AVDL $56.86
  • Revenue Next Year
  • NFE $12.64
  • AVDL $30.45
  • P/E Ratio
  • NFE N/A
  • AVDL N/A
  • Revenue Growth
  • NFE N/A
  • AVDL 252.64
  • 52 Week Low
  • NFE $2.01
  • AVDL $6.38
  • 52 Week High
  • NFE $20.91
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • NFE 50.58
  • AVDL 67.58
  • Support Level
  • NFE $3.59
  • AVDL $10.82
  • Resistance Level
  • NFE $4.91
  • AVDL $11.45
  • Average True Range (ATR)
  • NFE 0.53
  • AVDL 0.44
  • MACD
  • NFE 0.00
  • AVDL 0.13
  • Stochastic Oscillator
  • NFE 39.64
  • AVDL 83.02

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: